Pancreatic Cancer Research

Clinical trialNARecruiting

Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX

Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX: a Prospective, Pilot Study

NCT06349278↗ ClinicalTrials.gov, retrieved 4 November 2026

Outcome
Ongoing
Phase
NA
Status
Recruiting
Study type
Interventional
Start
16 January 2024
Expected end
16 January 2029
Enrollment
15 participants
Sites
1
Primary outcomes
Morbidity and mortality
Sponsor
Other
Results posted
No
Last update
16 April 2024

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Papers 12